New Rx, OTC, and generics (March 2010)

Key Points

RX CARE

New drugs

Genentech announced FDA approval of Actemra (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). The first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody approved to treat RA, Actemra may be used alone or in combination with methotrexate or other disease-modifying anti-rheumatic drugs. Visit http://www.actemra.com/ for more information, including boxed warnings and medication guide.

Elan and Acorda announced that FDA has approved Ampyra [1] (dalfampridine) extended-release tablets to improve walking in adults with multiple sclerosis (MS). Ampyra closes the exposed potassium channels on demyelinated axons, which cause nerve impulse "short circuits," thus improving nerve-impulse conduction. For more information, visit http://www.acorda.com/ or call 914-347-4300.

Fera has made available Bacitracin ophthalmic ointment, a sterile anti-infective ophthalmic agent available by prescription. Bacitracin ophthalmic ointment is indicated for the treatment of susceptible superficial ocular infections involving the conjunctiva and/or cornea. For more information, visit http://www.ferapharma.com/ or call 414-434-6604.

Fanapt (iloperidone) tablets are now available from Novartis. An atypical antipsychotic for the acute treatment of schizophrenia in adults, Fanapt is a mixed dopamine D₂/serotonin 5-HT_2A receptor antagonist. Call 888-669-6682 or visit http://www.fanapt.com/ for more information.

Alaven has made available sfROWASA [2] (mesalamine), a sulfite-free rectal suspension for the treatment of active mild-to-moderate distal ulcerative colitis (UC), proctosigmoiditis, or proctitis. sfROWASA is available in a 4 g/60 mL dosage strength. Visit http://www.alavenpharm.com/ or call 888-317-0001 for more information.

Hi-Tech Pharmacal annnounced FDA approval of Tropazone [3] lotion, a prescription product for the treatment of various dermatological conditions, including atopic dermatitis, allergic contact dermatitis, and radiation dermatitis. Tropazone uses lyphazome nanosphere technology. Visit http://www.hitechpharm.com/ or call 800-899-3116 for more information.

New OTC

General Mills has introduced Fiber One 90 Calorie Chewy Bars [4], described as a tasty and satisfying snack that makes weight management easier for busy consumers. Each bar contains only 90 calories, 5 g of fiber, and 2.5 g of fat to help dieters feel full and stick to their diet without compromising taste. The new bars are available in two varieties, chocolate and chocolate peanut butter. For more information, visit http://www.fiberone.com/.

Vitalah introduces two additions to its Oxylent [5] line: a new flavor, Sparkling Blackberry Pomegranate, and a new variety pack offering 10 packs each of its three flavors in one convenient box. All products will be sweetened with organic sugar and stevia. Each 6.5-g packet of Sparkling Berries, Sparkling Blackberry Pomegranate, or Sparkling Mandarin Oxylent powder can be mixed with four ounces of water for a refreshing and nutritious drink. Oxylent contains no gluten, caffeine, lactose, or artificial flavoring. For more information, call 877-699-5368.

Clerisy announces the launch of Nasal SoftStrips [6], designed to administer over-the-counter medications or essential oils through a convenient nasal strip. Market-approved by FDA, the doctor-developed Nasal SoftStrip is a patented medical delivery device designed to provide consumers with a safe, effective, and all-natural means for improving and managing their health and well-being. Two types of SoftStrips are available, a peppermint blend to curb appetite and a lavender blend to promote relaxation and provide relief from stress and tension. For more information, call 585-340-6166.

Sato introduces Zentrip, a fast-acting oral "thin strip" to help with the nausea, vomiting, and dizziness associated with motion sickness. Citrus-flavored medicated thin strips provide relief for 8 hours or longer when a quick-dissolving strip is placed on the tongue. For further information, visit http://www.zentripsato.com/.